Novartis Looks To Kill Gleevec Antitrust Suit
Novartis Pharmaceuticals Corp. told a Massachusetts federal judge to dismiss a proposed class action that claims the company illegally withheld generic versions of a leukemia drug from consumers, saying the plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article